SentreHEART Announces Participation at CSI LAA 2017 Frankfurt Conference

18:05 EST 15 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
SentreHEART, Inc., the manufacturer of the LARIAT® Suture Delivery Device (LARIAT) will be participating in the CSI LAA 2017 Scientific Program being held in Frankfurt, Germany November 17-18, 2017. This 2-day course will provi...

Other Sources for this Article

SentreHEART, Inc.
Leslie J. Hines


More From BioPortfolio on "SentreHEART Announces Participation at CSI LAA 2017 Frankfurt Conference"

Quick Search


Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...